Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.7.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Income Statement [Abstract]    
Sales $ 618,537 $ 391,898
Cost of sales (484,683) (334,727)
Gross profit 133,854 57,171
Operating Expenses    
Selling and marketing 151,040 46,204
General and administrative 1,782,885 1,679,981
Depreciation and amortization 21,615 26,037
Total operating expenses 1,955,540 1,752,222
Loss from Operations (1,821,686) (1,695,051)
Other Income (Expense)    
Interest expense, net (81,856) (27,252)
Gain on sale of investment in subsidiary 199,200
Total other income (expense) 117,344 (27,252)
Loss from Continuing Operations (1,704,342) (1,722,303)
Loss from Discontinued Operations (106,543) (273,962)
Net Loss (1,810,885) (1,996,265)
Deemed dividend to Series B preferred stockholders (3,053)
Net loss attributable to common stockholders $ (1,813,938) $ (1,996,265)
Net loss per basic and diluted common share:    
Loss from continuing operations $ (0.04) $ (0.04)
Loss from discontinued operations (0.00) (0.01)
Net loss per common share $ (0.04) $ (0.05)
Weighted Average Number of Common Shares Outstanding:    
Basic and Diluted 42,935,629 40,433,966